Menu
Wake-up call for sleep related CVD risk

Wake-up call for sleep re…

Geneva, Switzerland ...

New Cholesterol Treatment Guideline: A Q & A With Thomas Dayspring MD

New Cholesterol Treatment…

When I looked at ...

Second Response to "Lipid-Related Markers and Cardiovascular Disease Prediction"

Second Response to "…

Second Response ...

Coronary Calcium, Lipids, and Lipoproteins

Coronary Calcium, Lipids,…

Coronary Calc...

Basic Lipid & Lipoprotein Biochemistry

Basic Lipid & Lipopro…

This interactive pre...

Polycystic Ovarian Syndrome, Insulin Resistance, and Lipids

Polycystic Ovarian Syndro…

Polycystic Ovaria...

Long-overdue US guidelines for lipid management oversimplify the evidence

Long-overdue US guideline…

Long-overdue ...

Trans Hepatic Cholesterol Trafficking

Trans Hepatic Cholesterol…

How hepatocytes hand...

Prev Next
Sweet and Low BP Effects of antidiabetes meds- part 1

Sweet and Low BP Effects of antidiabetes meds- part 1

This lecture will discuss the impact of type 2 diabetes with co-morbid hypertension and the increase in cardiovascular and renal diseasee risk.  This series explores the mechanisms of newest antidiabetic classes of drugs, SGLT-2 inhibitors an...

Latest Lectures

HDL Mediated Cholesterol Transport Part 2

HDL Mediated Cholesterol Tra…

The HDL Biogenesis slide lecture is in three parts which collectively take the v...

Commentary on:  Use of low-density lipoprotein cholesterol gene score

Commentary on: Use of low-d…

Recently published in the Lancet was a study by Philippa Talmud and colleagues e...

Commentary response to JAMA on Omega-3 Fatty Acids

Commentary response to JAMA …

Cardiologist Dr. Seth Baum MD, FACC, FAHA of Boca Raton Florida recently sent a ...

Commentary: Diets to Prevent Coronary Heart Disease 1957- 2013: What Have We Learned?

Commentary: Diets to Prevent…

Commentary by Brian Edwards, MD regarding the manuscript: Diets to Prevent Co...

More Lectures!